These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22095644)

  • 81. DARPins bind their cytosolic targets after having been translocated through the protective antigen pore of anthrax toxin.
    Becker L; Plückthun A
    Sci Rep; 2023 May; 13(1):8048. PubMed ID: 37198284
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Membrane insertion by anthrax protective antigen in cultured cells.
    Qa'dan M; Christensen KA; Zhang L; Roberts TM; Collier RJ
    Mol Cell Biol; 2005 Jul; 25(13):5492-8. PubMed ID: 15964805
    [TBL] [Abstract][Full Text] [Related]  

  • 83. New insights into the pathogenesis and treatment of anthrax toxin-induced shock.
    Li Y; Sherer K; Cui X; Eichacker PQ
    Expert Opin Biol Ther; 2007 Jun; 7(6):843-54. PubMed ID: 17555370
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A model of anthrax toxin lethal factor bound to protective antigen.
    Lacy DB; Lin HC; Melnyk RA; Schueler-Furman O; Reither L; Cunningham K; Baker D; Collier RJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16409-14. PubMed ID: 16251269
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
    Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
    Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation.
    Dennis MK; Mogridge J
    Biochemistry; 2014 Apr; 53(13):2166-71. PubMed ID: 24641616
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Proteome analysis of mouse macrophages treated with anthrax lethal toxin.
    Chandra H; Gupta PK; Sharma K; Mattoo AR; Garg SK; Gade WN; Sirdeshmukh R; Maithal K; Singh Y
    Biochim Biophys Acta; 2005 Mar; 1747(2):151-9. PubMed ID: 15698949
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Molecular model of anthrax toxin translocation into target-cells].
    Noskov AN
    Bioorg Khim; 2014; 40(4):399-404. PubMed ID: 25898749
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low pH.
    Williams AS; Lovell S; Anbanandam A; El-Chami R; Bann JG
    Protein Sci; 2009 Nov; 18(11):2277-86. PubMed ID: 19722284
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Identification of new dominant-negative mutants of anthrax protective antigen using directed evolution.
    Wu G; Feng C; Cao S; Guo A; Liu Z
    Appl Biochem Biotechnol; 2012 Nov; 168(5):1302-10. PubMed ID: 22948605
    [TBL] [Abstract][Full Text] [Related]  

  • 91. New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.
    Guichard A; Nizet V; Bier E
    Microbes Infect; 2012 Feb; 14(2):97-118. PubMed ID: 21930233
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A kinetic analysis of protein transport through the anthrax toxin channel.
    Basilio D; Kienker PK; Briggs SW; Finkelstein A
    J Gen Physiol; 2011 Jun; 137(6):521-31. PubMed ID: 21624946
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Anthrax toxin: a tripartite lethal combination.
    Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
    FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
    Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
    J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
    Young JA; Collier RJ
    Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Editorial.
    Mock M; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):345-6. PubMed ID: 19733583
    [No Abstract]   [Full Text] [Related]  

  • 97. Cellular and physiological effects of anthrax exotoxin and its relevance to disease.
    Lowe DE; Glomski IJ
    Front Cell Infect Microbiol; 2012; 2():76. PubMed ID: 22919667
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.
    Chekanov AV; Remacle AG; Golubkov VS; Akatov VS; Sikora S; Savinov AY; Fugere M; Day R; Rozanov DV; Strongin AY
    Arch Biochem Biophys; 2006 Feb; 446(1):52-9. PubMed ID: 16384550
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Anthrax Toxin: Model System for Studying Protein Translocation.
    Krantz BA
    J Mol Biol; 2024 Apr; 436(8):168521. PubMed ID: 38458604
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.
    Kintzer AF; Sterling HJ; Tang II; Abdul-Gader A; Miles AJ; Wallace BA; Williams ER; Krantz BA
    J Mol Biol; 2010 Jun; 399(5):741-58. PubMed ID: 20433851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.